Javascript must be enabled to continue!
Bacterial pneumonia as an influenza complication
View through CrossRef
Purpose of review
The pathogenesis and impact of coinfection, in particular bacterial coinfection, in influenza are incompletely understood. This review summarizes results from studies on bacterial coinfection in the recent pandemic influenza outbreak.
Recent findings
Systemic immune mechanisms play a key role in the development of coinfection based on the complexity of the interaction of the host and the viral and bacterial pathogens. Several studies were performed to determine the point prevalence of bacterial coinfection in influenza. Coinfection in influenza is frequent in critically ill patients with Streptococcus pneumoniae being the most frequent bacterial pathogen and higher rates of potentially resistant pathogens over the years.
Summary
Bacterial pneumonia is certainly an influenza complication. The recent epidemiology findings have helped to partially resolve the contribution of different pathogens. Immunosuppression is a risk factor for bacterial coinfection in influenza, and the epidemiology of coinfection has changed over the years during the last influenza pandemic, and these recent findings should be taken into account during present outbreaks.
Ovid Technologies (Wolters Kluwer Health)
Title: Bacterial pneumonia as an influenza complication
Description:
Purpose of review
The pathogenesis and impact of coinfection, in particular bacterial coinfection, in influenza are incompletely understood.
This review summarizes results from studies on bacterial coinfection in the recent pandemic influenza outbreak.
Recent findings
Systemic immune mechanisms play a key role in the development of coinfection based on the complexity of the interaction of the host and the viral and bacterial pathogens.
Several studies were performed to determine the point prevalence of bacterial coinfection in influenza.
Coinfection in influenza is frequent in critically ill patients with Streptococcus pneumoniae being the most frequent bacterial pathogen and higher rates of potentially resistant pathogens over the years.
Summary
Bacterial pneumonia is certainly an influenza complication.
The recent epidemiology findings have helped to partially resolve the contribution of different pathogens.
Immunosuppression is a risk factor for bacterial coinfection in influenza, and the epidemiology of coinfection has changed over the years during the last influenza pandemic, and these recent findings should be taken into account during present outbreaks.
Related Results
Correlation of Influenza Vaccination and Influenza Incidence on COVID-19 Severity and Other Perspectives
Correlation of Influenza Vaccination and Influenza Incidence on COVID-19 Severity and Other Perspectives
The pandemic of COVID-19 is evolving worldwide, and it is associated with high mortality and morbidity. There is a growing need to discuss the elements of a coordinated strategy to...
1395. Influenza B-Associated Pediatric Mortality in the US Between 2010 and 2019
1395. Influenza B-Associated Pediatric Mortality in the US Between 2010 and 2019
Abstract
Background
To assess the contribution of influenza B to mortality in the US pediatric population, we analyzed the propo...
Assessement of the influenza burden in nursing homes during two influenza seasons
Assessement of the influenza burden in nursing homes during two influenza seasons
Abstract
Influenza is a significant cause of morbidity and mortality in elderly. They are at high risk of complications after i...
A New Influenza-Tracking Smartphone App (Flu-Report) Based on a Self-Administered Questionnaire: Cross-Sectional Study (Preprint)
A New Influenza-Tracking Smartphone App (Flu-Report) Based on a Self-Administered Questionnaire: Cross-Sectional Study (Preprint)
BACKGROUND
Influenza infections can spread rapidly, and influenza outbreaks are a major public health concern worldwide. Early detection of signs of an infl...
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
Please cite this paper as: Borders‐Hemphill and Mosholder (2012) U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic. Influenza and...
Clinical characteristics and outcomes of patients with H1N1 influenza pneumonia admitted at a tertiary care hospital in Karachi, Pakistan
Clinical characteristics and outcomes of patients with H1N1 influenza pneumonia admitted at a tertiary care hospital in Karachi, Pakistan
Abstract
Introduction
Influenza viruses specifically, A and B mainly contribute to seasonal outbreaks that occur globally. However, due to limited diagnostics for influenza there i...
Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017
Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017
Abstract
Background
The influenza virus spreads rapidly around the world in seasonal epidemics, resulting in significant morbidity and mortality. In...
The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated against Influenza Pediatric Patients in Two In-fluenza seasons after the COVID-19 pandemic.The Impact of Comorbidities on Hospitalization for Influenza in Children.
The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated against Influenza Pediatric Patients in Two In-fluenza seasons after the COVID-19 pandemic.The Impact of Comorbidities on Hospitalization for Influenza in Children.
Antiviral therapy such as Oseltamivir has been recommended for hospitalized children with suspected and confirmed influenza for almost 20 years. The therapy is officially authorize...

